Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Omnicell (OMCL) Notes Payables (2021 - 2025)

Omnicell has reported Notes Payables over the past 4 years, most recently at $174.8 million for Q2 2025.

Quarterly Notes Payables changed N/A to $174.8 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $174.8 million through Jun 2025, changed N/A year-over-year, with the annual reading at $174.3 million for FY2024, N/A changed from the prior year.
Notes Payables was $174.8 million for Q2 2025 at Omnicell, roughly flat from $174.6 million in the prior quarter.
Over five years, Notes Payables peaked at $572.0 million in Q3 2024 and troughed at $174.3 million in Q4 2024.
The 4-year median for Notes Payables is $331.5 million (2021), against an average of $358.0 million.